Prostate cancer
Conditions
Interventions
Experiment 1:The patient was first injected with two cycles of Norrade and then received two cycles of Bactovir
Experiment 2:First, inject two cycles of Biotovir and then receive two cycles of Norrade
Sponsors
The First Affiliated Hospital of Xiamen University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Prostate cancer confirmed by histology; 2. Age >=18 years old; 3.ECOG score: 0-2 points; 4. The researcher determined that ADT drug treatment was necessary; 5. Has not received ADT drug treatment in the past or has been using ADT for less than 6 months and has stopped for more than 6 months; 6. Life expectancy > 1 year; 7. Good liver and kidney functions; 8. Good compliance;
Exclusion criteria
Exclusion criteria: 1.;Diagnosed or suspected hormone resistant prostate cancer with pituitary resection, adrenalectomy or pituitary lesions; 2.History of cardiovascular events, uncontrolled hypertension, gastrointestinal diseases that interfere with treatment absorption, active viral hepatitis or active human immunodeficiency infection in the past 6 months; 3.There is any disease that the investigator believes makes the patient unfit to participate in the study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient preference for medication choice; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain at injection site;Incidence of local adverse reactions at the injection site of ADT;Quality of life of patients during treatment;Serum testosterone;The PSA level during ADT treatment;Fatigue of patients during treatment; | — |
Countries
China
Contacts
Public ContactXuegang Wang
The First Affiliated Hospital of Xiamen University
Outcome results
None listed